Texas Children's Cancer Center

Houston, Texas 77030-2399

2 studies enrolling now · 36 studies all time

What they study most

Brain Tumor, Brain Tumor, Pediatric, Brain Tumor, Recurrent, Brain and Central Nervous System Tumors, CNS Embryonal Tumor, Not Otherwise Specified, Central Nervous System Neoplasms, Central Nervous System Tumor, Central Nervous System Tumor, Pediatric, Ependymoma, Hemophagocytic Lymphohistiocytosis, High Grade Glioma (HGG) of the Brain With BRAF Aberration, Infusion Reactions

Studies at this site

• Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation — Recruiting now
• Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors — Recruiting now
• A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma — Completed
• HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma — Running, not enrolling
• A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration — Running, not enrolling
• A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma — Running, not enrolling
• A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) or With Ph+ Leukemias Resistant or Intolerant to Imatinib — Completed
• RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System Tumors — Stopped early
• N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma — Completed
• Study to Investigate Safety, Efficacy of an Anti-IFNγ mAb in Children With Primary Haemophagocytic Lymphohistiocytosis — Completed
• A Study for Long-term Follow-up of Hemophagocytic Lymphohistiocytosis (HLH) Participants Who Received Treatment With Emapalumab (NI-0501), an Anti-interferon Gamma Monoclonal Antibody — Completed
• Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL) — Completed
• Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia — Completed
• Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors — Completed
• A Study of Lenalidomide in Pediatric Subjects With Relapsed or Refractory Acute Myeloid Leukemia — Completed
• Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas — Completed
• Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors — Completed
• Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma — Completed
• Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) Patients — Completed
• Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors — Completed
• Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors — Completed
• Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement — Completed
• Irinotecan in Treating Children With Refractory or Progressive Solid Tumors — Completed
• Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors — Completed
• Irofulven in Treating Children With Recurrent or Refractory Solid Tumors — Completed
• O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors — Completed
• Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia — Completed
• Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia — Completed
• Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor — Completed
• Tipifarnib in Treating Young Patients With Refractory Leukemia — Completed
• Genetic Study of Brain Tumors in Young Children — Stopped early
• N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma — Completed
• Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors — Status unconfirmed
• Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent Malignant Glioma — Stopped early
• Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor — Completed
• SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors — Completed